For instance, in the perspective of a LAM immunotherapy, it was demonstrated that LAM lung sections of both patients and Tsc2–/– mice have a strong positivity to the ganglioside D3 (GD3), whose expression is a characteristic that LAM cells maintain also after multiple passages in vitro (61). The gene discussed is TSC2; the disease is lymphangioleiomyomatosis.